Responsiveness of parathyroid hormone secretion to a phosphate load in hypertensive patients with non insulin dependent diabetes mellitus;Wydzielanie parathormonu stymulowane doustnym obcia̧żeniem fosforanem sodowym u chorych na cukrzycȩ typu 2 z nadciśnieniem tȩtniczym

Endokrynologia Polska

Volumn 60, Issue 3, 2009, Pages 180-188

  Irzyniec, Tomasz ^a,b  

^a MEDICAL UNIVERSITY OF SILESIA   (Poland)

^b Oddzia Nefrologii ze Stacja Dializ Szpitala Ministerstwa Spraw Wewnetrznych I Administracji   (Poland)

Author keywords

Arterial hypertension; Non insulin dependent diabetes mellitus; Parathyroid hormone

Indexed keywords

CALCIFEDIOL; CALCIUM ION; PHOSPHATE; CALCIUM; COLECALCIFEROL; PARATHYROID HORMONE;

ADULT; AREA UNDER THE CURVE; ARTICLE; BODY MASS; CALCIUM BLOOD LEVEL; CALCIUM EXCRETION; CALCIUM METABOLISM; CALCIUM URINE LEVEL; CONTROLLED STUDY; CREATININE BLOOD LEVEL; DOSE TIME EFFECT RELATION; ESSENTIAL HYPERTENSION; FEMALE; HUMAN; HYPERTENSION; MAJOR CLINICAL STUDY; MALE; MEAN ARTERIAL PRESSURE; NON INSULIN DEPENDENT DIABETES MELLITUS; PARATHYROID HORMONE BLOOD LEVEL; PARATHYROID HORMONE RELEASE; PHOSPHATE BLOOD LEVEL; PHOSPHATE METABOLISM; URINARY EXCRETION; BLOOD; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; METABOLISM; MIDDLE AGED; ORAL DRUG ADMINISTRATION; SECRETION; URINE;

ADMINISTRATION, ORAL; AREA UNDER CURVE; CALCIUM; CHOLECALCIFEROL; DIABETES MELLITUS, TYPE 2; FEMALE; HUMANS; HYPERTENSION; MALE; MIDDLE AGED; PARATHYROID HORMONE; PHOSPHATES;

EID: 67749113398     PISSN: 0423104X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (22)

1. Januszewicz A. Nadciśnienie tȩtnicze - zarys patogenezy, diagnostyki i leczenia. Medycyna Praktyczna, Kraków 2007.
2. Sieradzki J. Cukrzyca. Gdańsk, Via Medica 2007.
3. Mc Caron DA. Calcium metabolism and hypertension. Kidney Int 1989; 35: 717-736.
4. Irzyniec T. Gospodarka wapniowo-fosforanowa u hipertensyjnych i normotensyjnych chorych z cukrzyrca̧ typu 2. Rozprawa habilitacyjna. Annates Academiae Medicae Silesiensis. Ślaska Akademia Medyczna w Katowicach, Katowice 1999.
5. Liu S, Darryl Quarles L. How Fibroblast Growth Factor 23 Works. J Am Soc Nephrol 2007; 18: 1637-1647. (Pubitemid 46870300)
6. Allender PS, Cutler JA, Follman D i wsp. Dietary calcium and blood pressure: a meta-analysis of randomized clinical trials. Ann Inter Med 1996; 124: 825-831.
7. Seleh F, Jorde R, Svartberg J i wsp. The relationship between blood pressure and serum parathyroid hormone with special reference to urinary calcium excretion: the Tromso study. J Endocrinol Invest 2006; 29: 214-220.
8. Simonetti G, Mohaupt M. Calcium and blood pressure. Ther Umsch 2007; 64: 249-252.
9. Perlzweig WA, Latham E, Keefer CS. The behavior of inorganic phosphate in the blood and urine of normal and diabetic subjects during carbohydrate metabolism. Proc Soc Exp Biol Med 1923; 21: 33-43.
10. Kokot F, Bułanowski M, Ficek R i wsp. Gospodarka wodno-elektrolitowa i kwasowo-zasadowa w stanach fizjologii i patologii. PZWL, Warszawa 2005.
11. Hammerman MR, Rogers S, Hansen VA i wsp. Insulin stimulates Pi transport in brushborder vesicles form proximal tubular segments. Am J Physiol 1984; 247: E616-E624.
12. Irzyniec T, Kokot F. Wpływ leczenia przeciwnadciśnieniowego na sekrecjȩ parathormonu stymulowana̧ doustnym obcia̧zeniem fosforanami u chorych na nadciśnienie tȩtnicze i chorych na cukrzycȩ typu 2 ze wspo̧łistnieja̧cym nadciśnieniem. Nadciśnienie Tȩtnicze 2008; 12: 169-181.
13. Kokot F. Metody badań laboratoryjnych stosowane w klinice. PZWL, Warszawa 1969.
14. Kokot F, Stupnicki R. Metody radioimmunologiczne i radiokompetycyjne stosowane w klinice. PZWL, Warszawa 1979.
15. Felicetta JV. Age-related changes in calcium metabolism. Why they occur and what can be done? Postgrad Med 1989; 85: 85-94.
16. Kaye M. Hypocalcemia after an acute phosphate load is secondary to reduced calcium efflux from bone: studies in patients with minimal renal function and varying parathyroid activity. J Am Soc Nephrol 1995; 6: 273-280.
17. Massry S.G, Weidmann P, Llach F. Blood calcium levels and hypertension. Contrib Nephrol 1977; 8: 117-125.
18. Lind L, Berne C, Pollare T i wsp. Metabolic effects of antihypertensive treatment with nifedipine or furosemide: A double-blind, cross-over study. J Hum Hypertens 1995; 9: 137-141.
19. Lind L, Berne C, Lithell H. Prevalence of insulin resistance in essential hypertension. J Hypertens 1995; 13: 1457-1462. (Pubitemid 26015762)
20. Nowicki M, Fliser D, Fode P i wsp. Changes in plasma phosphate levels influence insulin sensitivity under euglycemic conditions. J Clin Endocrinol Metab 1996; 81: 156-159. (Pubitemid 26035018)
21. Kaye M. Hypocalcemia after an acute phosphate load is secondary to reduced calcium efflux from bone: studies in patients with minimal renal function and varying parathyroid activity. J Am Soc Nephrol 1995; 6: 273-280.
22. Almaden Y, Hernandez A, Torregrosa V i wsp. Rodriguez M. High phosphate level directly stimulates parathyroid hormone secretion and synthesis by human parathyroid tissue in vitro. J Am Soc Nephrol 1998; 9: 1845-1852.